DK2996701T3 - Sammensætning omfattende mælkesyrebakterier til anvendelse i den forebyggende og/eller helbredende behandling af bakteriel vaginose - Google Patents

Sammensætning omfattende mælkesyrebakterier til anvendelse i den forebyggende og/eller helbredende behandling af bakteriel vaginose Download PDF

Info

Publication number
DK2996701T3
DK2996701T3 DK14733289.4T DK14733289T DK2996701T3 DK 2996701 T3 DK2996701 T3 DK 2996701T3 DK 14733289 T DK14733289 T DK 14733289T DK 2996701 T3 DK2996701 T3 DK 2996701T3
Authority
DK
Denmark
Prior art keywords
preventative
lactic acid
acid bacteria
composition including
bacterial vaginosis
Prior art date
Application number
DK14733289.4T
Other languages
English (en)
Inventor
Giovanni Mogna
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Application granted granted Critical
Publication of DK2996701T3 publication Critical patent/DK2996701T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK14733289.4T 2013-05-14 2014-05-14 Sammensætning omfattende mælkesyrebakterier til anvendelse i den forebyggende og/eller helbredende behandling af bakteriel vaginose DK2996701T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000794A ITMI20130794A1 (it) 2013-05-14 2013-05-14 Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.
PCT/IB2014/000739 WO2014184643A1 (en) 2013-05-14 2014-05-14 Composition comprising lactic acid bacteria for use in the preventive and/or curative treatment of bacterial vaginosis

Publications (1)

Publication Number Publication Date
DK2996701T3 true DK2996701T3 (da) 2020-09-21

Family

ID=48748369

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14733289.4T DK2996701T3 (da) 2013-05-14 2014-05-14 Sammensætning omfattende mælkesyrebakterier til anvendelse i den forebyggende og/eller helbredende behandling af bakteriel vaginose

Country Status (11)

Country Link
US (1) US20160184372A1 (da)
EP (1) EP2996701B1 (da)
JP (1) JP6509822B2 (da)
KR (1) KR102434323B1 (da)
CN (1) CN105263504A (da)
BR (1) BR112015028385A2 (da)
CA (1) CA2912015A1 (da)
DK (1) DK2996701T3 (da)
IT (1) ITMI20130794A1 (da)
RU (1) RU2015148752A (da)
WO (1) WO2014184643A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
EP3064072A1 (en) * 2015-02-11 2016-09-07 AB-Biotics S.A. Probiotic lactobacillus strains for use in treating urinary tract infections
MA45334A (fr) * 2016-03-24 2019-01-30 Probiotical Spa Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
BR112018068466A2 (pt) * 2016-03-24 2019-01-22 Probiotical Spa composição de bactérias ácido-lácticas para o tra-tamento de infecções vaginais bacterianas por gardnerella vaginalis e, se presentes, de infecções fúngicas concomitantes
AU2017296016A1 (en) * 2016-07-11 2019-01-24 Hennepin Life Sciences, Llc Compositions for sexually transmitted diseases
IT201600084470A1 (it) 2016-08-10 2018-02-10 Probiotical Spa Composizione per uso nel trattamento del disturbo depressivo maggiore
CN106265864A (zh) * 2016-08-30 2017-01-04 王守亮 一种用于生殖系统的复合益生菌及其制备方法和用途
EP3522879A4 (en) * 2016-10-04 2020-06-03 Evofem, Inc. METHOD OF TREATING AND PREVENTING BACTERIAL VAGINOSIS
EP3427745A1 (en) 2017-07-12 2019-01-16 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO New probiotic composition for prevention of bacterial vaginosis
WO2019088379A1 (ko) 2017-11-02 2019-05-09 경희대학교 산학협력단 신규 유산균 및 이의 용도
US11458176B2 (en) 2017-12-19 2022-10-04 Probiotical S.P.A. Composition for use in the treatment and/or improvement of sleep and mood disorders
BR112020012104A2 (pt) * 2017-12-19 2020-11-24 Probiotical S.P.A. composição para uso no tratamento e/ou melhoria de distúrbios do sono e humor
CN108295096B (zh) * 2017-12-21 2020-12-25 天津科睿恒生物科技有限公司 菌株在预防和治疗霉菌性、细菌性阴道炎制剂中的应用
US10456430B1 (en) 2018-05-25 2019-10-29 Genmont Biotech Incorporation Lactobacillus composition for prevention and treatment of bacterial vaginosis
EP3870196A1 (en) * 2018-10-26 2021-09-01 LAC2BIOME S.r.l. Bacterial strains of the lactobacillus paracasei species for use, oral or topical, in the treatment of disorders of the female urogenital tract
CN109439592A (zh) * 2018-12-06 2019-03-08 青岛东海药业有限公司 植物乳杆菌制剂及其应用
CN111632073A (zh) * 2019-03-01 2020-09-08 王飞 一种抗菌消炎的女性私密益生菌组合物及其制备
CN110664731A (zh) * 2019-11-25 2020-01-10 哈尔滨欧替药业有限公司 一种含有乳酸杆菌和低聚糖的阴道膨胀栓及其制备方法
IT202000004663A1 (it) * 2020-03-05 2021-09-05 Marca Antonio La Nuovo uso di probiotici
US20230135760A1 (en) 2020-03-16 2023-05-04 Biosearch, S.A. Biocomposites comprising probiotics, collagen and bacterial extracellular polysaccharide and uses thereof
CA3204068A1 (en) * 2021-01-05 2022-07-14 Charlotte VEDEL Strains, compositions and methods of use
IT202100015398A1 (it) * 2021-06-11 2022-12-11 Probiotical Spa Ceppi di batteri probiotici per uso in un metodo di trattamento preventivo o in un metodo di trattamento coadiuvante per le infezioni respiratorie virali
WO2023220318A2 (en) * 2022-05-12 2023-11-16 Bcd Bioscience, Inc. Methods for treating urogenital health conditions
CN115418338B (zh) * 2022-11-03 2023-02-24 山东锦鲤生物工程有限公司 副干酪乳杆菌及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ512275A (en) * 1998-12-11 2003-11-28 Urex Biotech Inc Probiotic therapy delivered to women by oral administration of selected lactobascilli that have antagonistic properties against urogenital pathogens
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
DE602004007813T2 (de) * 2004-08-05 2008-04-17 Anidral S.R.L. Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung
WO2007125558A1 (en) * 2006-05-03 2007-11-08 Anidral S.R.L. Symbiotic composition comprising non-digestible polysaccharides and bifidobacteria which metabolize them and its uses
ITMI20061841A1 (it) * 2006-09-27 2008-03-28 Mofin S R L Colture liquide microbiche ad elevata stabilita' ed attivita' fermentativa
CN109010900A (zh) * 2006-11-17 2018-12-18 Sca卫生用品公司 包含微生物抑制性组合物的卫生织物
ITMI20062286A1 (it) * 2006-11-28 2008-05-29 Anidral Srl Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
PL210465B1 (pl) * 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
US20120064118A1 (en) * 2009-03-05 2012-03-15 Probiotical S.P.A. Bacteria strains having a high anti-inflammatory activity
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
IT1397566B1 (it) * 2009-05-27 2013-01-16 Probiotical Spa Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
MX2012001269A (es) * 2009-07-27 2012-03-16 Nestec Sa Composiciones nutricionales que contienen fibra y probioticos.
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITRM20110477A1 (it) * 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITRM20110475A1 (it) * 2011-09-09 2013-03-10 Probiotical Spa Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e

Also Published As

Publication number Publication date
EP2996701B1 (en) 2020-06-24
WO2014184643A1 (en) 2014-11-20
KR102434323B1 (ko) 2022-08-18
KR20160007608A (ko) 2016-01-20
ITMI20130794A1 (it) 2014-11-15
EP2996701A1 (en) 2016-03-23
JP2016520076A (ja) 2016-07-11
CA2912015A1 (en) 2014-11-20
US20160184372A1 (en) 2016-06-30
JP6509822B2 (ja) 2019-05-08
BR112015028385A2 (pt) 2017-07-25
CN105263504A (zh) 2016-01-20
RU2015148752A (ru) 2017-06-20

Similar Documents

Publication Publication Date Title
DK2996701T3 (da) Sammensætning omfattende mælkesyrebakterier til anvendelse i den forebyggende og/eller helbredende behandling af bakteriel vaginose
DK2996700T3 (da) Sammensætning omfattende mælkesyrebakterier til anvendelse i den forebyggende og/eller helbredende behandling af infektioner og/eller inflammationer i urinvejen og/eller blæren
HK1254897A1 (zh) 用於治療由痤瘡丙酸桿菌引起的感染尤其是痤瘡的乳酸菌的組合物
DK3377637T3 (da) Sammensætninger til anvendelse i fremgangsmåder til behandling af sår, lidelser og sygdomme i huden
DK3628161T3 (da) Synergistiske bakterielle sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
HK1232120A1 (zh) 喹啉衍生物用於治療軟組織肉瘤的方法和用途以及用於治療軟組織肉瘤的藥物組合物
ZA201706348B (en) Heterocyclic compounds and their use in preventing or treating bacterial infections
DK2815769T3 (da) Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet
DK3212204T3 (da) Mikroniserede æggeskalsmembranpartikler og anvendelsen deraf til at fremme helingen af sår
DK3074008T3 (da) Forbindelser, farmaceutisk sammensætning og fremgangsmåder til anvendelse i behandling af inflammation
DK2854910T3 (da) Ceramidniveauer i behandling og forebyggelse af infektioner
IL251351B (en) Preparations for use in the treatment and prevention of surgical infections
DK2836203T3 (da) Vesikulær formulering til anvendelse til behandling af smerter eller nedsat mobilitet i et led
DK3456334T3 (da) Mælkesyrebakterier til anvendelse i forebyggelse af knogletab hos pattedyr
SG11201610413RA (en) Lactic acid bacteria suppressing purine absorption and use thereof
DK3260865T3 (da) Fremgangsmåde til behandling af blod, blodprodukter og organer
DK3102218T3 (da) Behandling af topiske og systemiske bakterieinfektioner
HK1248756A1 (zh) 乳酸菌及其用於治療乳腺炎的用途
HK1243951A1 (zh) 抗微生物組合和其在治療微生物感染中的用途
DK3363437T3 (da) Aminoindanforbindelser og anvendelse deraf i behandling af smerte
DK3373922T3 (da) Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri
DK3285787T3 (da) Behandling af bakterieinfektioner i akvakultur
HK1219690A1 (zh) 利用抗生素來治療超重和肥胖患者感染的方法
HK1244791A1 (zh) 雜環化合物及它們在預防或治療細菌感染中的應用
IN2013MU03216A (da)